Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
HIV Transmission
100%
Breast Milk
100%
Zimbabwean Women
100%
Prospective Cohort Study
100%
Polymerase Chain Reaction
75%
HIV-positive
75%
HIV-negative
75%
Breast
50%
Enzyme-linked Immunosorbent Assay (ELISA)
50%
Mother-to-child Transmission
50%
Maternal Infection
50%
Infant Infections
50%
Clinical Trials
25%
Zimbabwe
25%
Vitamins
25%
Trial Registration
25%
Plasma Samples
25%
With Woman
25%
Seroconversion
25%
Precise Timing
25%
HIV-associated
25%
Age of Infection
25%
Postpartum Period
25%
Antibody Test
25%
Maternal Plasma
25%
Maternal Breastfeeding
25%
Maternal HIV Infection
25%
After Delivery
25%
Positive Test
25%
Urban Zimbabwe
25%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Prospective Cohort Study
100%
Infection
50%
Human Milk
28%
Polymerase Chain Reaction
21%
Enzyme Linked Immunosorbent Assay
14%
Breast Feeding
14%
Human Immunodeficiency Virus Infection
7%
Clinical Trial
7%
HIV Test
7%
Retinol
7%
Seroconversion
7%
Maternal Plasma
7%
Puerperium
7%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Prospective Cohort Study
100%
Infection
50%
Polymerase Chain Reaction
21%
Enzyme Linked Immunosorbent Assay
14%
Breast Feeding
14%
Puerperium
7%
HIV Test
7%
Human Immunodeficiency Virus Infection
7%
Clinical Trial
7%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Prospective Cohort Study
100%
Blood Plasma
25%
Polymerase Chain Reaction
18%
Enzyme
12%
Clinical Trial
6%
Vitamin A
6%
Seroconversion
6%
Window Period
6%
Puerperium
6%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Infectious Disease
46%
Infection
46%
Blood Plasma
20%
Polymerase Chain Reaction
20%
Enzyme-Linked Immunosorbent Assay
13%
Human Immunodeficiency Virus Infection
6%
Seroconversion
6%
Puerperium
6%
Window Period
6%
Maternal Plasma
6%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Prospective Cohort Study
100%
Infection
46%
Enzyme-Linked Immunosorbent Assay
13%
Clinical Trial
6%
Human Immunodeficiency Virus Infection
6%